Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Pharmacotherapy|January 18, 2023
Adverse Effects of Antidepressant Medications and their Management in Children and AdolescentsJeffrey R Strawn, Jeffrey A Mills, Ethan A Poweleit, et al.Child Psychiatry and Human Development|September 2, 2023
Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and Their Relationship to Selective Serotonin Reuptake Inhibitor Treatment or PlaceboW Thomas Baumel, Jeffrey A Mills, Heidi K Schroeder, et al.Journal of Affective Disorders|November 3, 2021
Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxietyJeffrey R Strawn, Jeffrey A Mills, Vikram Suresh, et al.Journal of the American Academy of Child and Adolescent Psychiatry|February 24, 2023
The Impact of COVID-19 Infection and Characterization of Long COVID in Adolescents With Anxiety Disorders: A Prospective Longitudinal StudyJeffrey R Strawn, Jeffrey A Mills, Heidi K Schroeder, et al.Journal of Child and Adolescent Psychopharmacology|June 22, 2023
What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-AnalysisEric M Mendez, Katherine K Dahlsgaard, John M Hjelmgren, et al.Psychiatric Services (Washington, D.C.)|March 31, 2022
Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive DisorderJeffrey A Mills, Vikram Suresh, Lenisa Chang, et al.Journal of Psychiatric Research|February 12, 2023
The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorderJeffrey R Strawn, Jeffrey A Mills, Vikram Suresh, et al.The Journal of Clinical Psychiatry|December 8, 2022
Initiation of Pharmacotherapy Following CBT in Anxious Youth: Results From the Child/Adolescent Anxiety Multimodal Study (CAMS)Jeffrey R Strawn, Jeffrey A Mills, Richard Rothenberg, et al.Journal of Child and Adolescent Psychopharmacology|May 9, 2022
Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled TrialW Thomas Baumel, Jeffrey A Mills, Heidi K Schroeder, et al.Journal of Child and Adolescent Psychopharmacology|July 1, 2026
Beyond the Wait-and-See: Data-Driven Decision Points for Guiding Selective Serotonin Reuptake Inhibitor Treatment and Cognitive Behavioral Therapy in Pediatric Anxiety DisordersJulia N Stimpfl, Jeffrey A Mills, Katherine K Dahlsgaard, et al.Pageof 4